Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | EIK1001 |
Trade Name | |
Synonyms | EIK-1001|EIK 1001 |
Drug Descriptions |
Limited information is currently available on EIK1001, a putative TLR 7/8 co-agonist (Feb 2024). |
DrugClasses | TLR7 Agonist 11 TLR8 Agonist 9 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + EIK1001 + Paclitaxel + Pembrolizumab | Carboplatin EIK1001 Paclitaxel Pembrolizumab | 0 | 1 |
Carboplatin + EIK1001 + Pembrolizumab + Pemetrexed Disodium | Carboplatin EIK1001 Pembrolizumab Pemetrexed Disodium | 0 | 1 |
EIK1001 | EIK1001 | 0 | 0 |